Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D06KOM
|
|||
| Former ID |
DNCL002727
|
|||
| Drug Name |
DN24-02
|
|||
| Synonyms |
Lapuleucel-T
Click to Show/Hide
|
|||
| Indication | Colorectal cancer [ICD-11: 2B91.Z] | Phase 2 | [1] | |
| Urogenital cancer [ICD-11: 2C95-2C9Z] | Phase 2 | [1] | ||
| Company |
Dendreon
|
|||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | ClinicalTrials.gov (NCT01353222) DN24-02 as Adjuvant Therapy in Subjects With High Risk HER2+ Urothelial Carcinoma. U.S. National Institutes of Health. | |||
| REF 2 | Treatment with autologous antigen-presenting cells activated with the HER-2 based antigen Lapuleucel-T: results of a phase I study in immunologic and clinical activity in HER-2 overexpressing breast cancer. J Clin Oncol. 2007 Aug 20;25(24):3680-7. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.